Prasugrel Switching Study in Patients With Acute Coronary Syndrome (ACS) Who Underwent Percutaneous Coronary Intervention (PCI)

NCT03672097 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

204

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Coronary Syndrome (ACS)

Interventions

DRUG: Prasugrel

Sponsor

Daiichi Sankyo Taiwan Ltd., a Daiichi Sankyo Company